354 related articles for article (PubMed ID: 30958703)
1. Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics.
Thakuri PS; Gupta M; Plaster M; Tavana H
Assay Drug Dev Technol; 2019 Apr; 17(3):140-149. PubMed ID: 30958703
[TBL] [Abstract][Full Text] [Related]
2. A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer.
Chen J; Dai J; Kang Z; Yang T; Zhao Q; Zheng J; Zhang X; Zhang J; Xu J; Sun G; Yang L; Yang T
Exp Cell Res; 2020 Aug; 393(1):112060. PubMed ID: 32407729
[TBL] [Abstract][Full Text] [Related]
3. Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cells.
Witteck L; Jaster R
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):642-50. PubMed ID: 26663013
[TBL] [Abstract][Full Text] [Related]
4. Novel 3D Liquid Cell Culture Method for Anchorage-independent Cell Growth, Cell Imaging and Automated Drug Screening.
Abe-Fukasawa N; Otsuka K; Aihara A; Itasaki N; Nishino T
Sci Rep; 2018 Feb; 8(1):3627. PubMed ID: 29483620
[TBL] [Abstract][Full Text] [Related]
5. Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines.
Koch J; Mönch D; Maaß A; Gromoll C; Hehr T; Leibold T; Schlitt HJ; Dahlke MH; Renner P
PLoS One; 2021; 16(1):e0244513. PubMed ID: 33395433
[TBL] [Abstract][Full Text] [Related]
6. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers.
Dai X; Xia H; Zhou S; Tang Q; Bi F
Cancer Lett; 2019 Feb; 442():202-212. PubMed ID: 30429107
[TBL] [Abstract][Full Text] [Related]
8. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
9. Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.
Grayson KA; Jyotsana N; Ortiz-Otero N; King MR
PLoS One; 2021; 16(3):e0246733. PubMed ID: 33661931
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in
Weisner J; Landel I; Reintjes C; Uhlenbrock N; Trajkovic-Arsic M; Dienstbier N; Hardick J; Ladigan S; Lindemann M; Smith S; Quambusch L; Scheinpflug R; Depta L; Gontla R; Unger A; Müller H; Baumann M; Schultz-Fademrecht C; Günther G; Maghnouj A; Müller MP; Pohl M; Teschendorf C; Wolters H; Viebahn R; Tannapfel A; Uhl W; Hengstler JG; Hahn SA; Siveke JT; Rauh D
Cancer Res; 2019 May; 79(9):2367-2378. PubMed ID: 30858154
[TBL] [Abstract][Full Text] [Related]
11. Novel three-dimensional cultures provide insights into thyroid cancer behavior.
Lee MA; Bergdorf KN; Phifer CJ; Jones CY; Byon SY; Sawyer LM; Bauer JA; Weiss VL
Endocr Relat Cancer; 2020 Feb; 27(2):111-121. PubMed ID: 31804972
[TBL] [Abstract][Full Text] [Related]
12. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs.
Nunes AS; Barros AS; Costa EC; Moreira AF; Correia IJ
Biotechnol Bioeng; 2019 Jan; 116(1):206-226. PubMed ID: 30367820
[TBL] [Abstract][Full Text] [Related]
13. Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells.
Geng R; Tan X; Zuo Z; Wu J; Pan Z; Shi W; Liu R; Yao C; Wang G; Lin J; Qiu L; Huang W; Chen S
Chin J Cancer; 2017 Jul; 36(1):63. PubMed ID: 28756770
[TBL] [Abstract][Full Text] [Related]
14. Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma.
Zoetemelk M; Rausch M; Colin DJ; Dormond O; Nowak-Sliwinska P
Sci Rep; 2019 May; 9(1):7103. PubMed ID: 31068603
[TBL] [Abstract][Full Text] [Related]
15. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
16. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
17. Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate.
Lee SY; Teng Y; Son M; Ku B; Hwang HJ; Tergaonkar V; Chow PK; Lee DW; Nam DH
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443536
[TBL] [Abstract][Full Text] [Related]
18. Robotic printing and drug testing of 384-well tumor spheroids.
Ham SL; Thakuri PS; Tavana H
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
[TBL] [Abstract][Full Text] [Related]
19. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
[TBL] [Abstract][Full Text] [Related]
20. Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroids.
Lamichhane A; Thakuri PS; Rafsanjani Nejad P; Tavana H
Exp Biol Med (Maywood); 2021 Nov; 246(22):2372-2380. PubMed ID: 34102903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
